Specifically, genes involved in EMT [43], such as β-catenin, L1CAM, fibronectin, and SNAIL2, as well as genes involved in stemness [44], such as Nestin, Oct4, Musashi, Pax6, and Nanog, were significantly induced upon the TMZ+AT101/AT101 therapy in surviving GBM cells. This evidence concerns the gene FN1 and glioblastoma.